A 12-year-old boy with a 2-year history of seizures and mild intellectual disability presents to the dermatology clinic. On examination, he has multiple symmetric small reddish-brown papules distributed over his nasolabial folds and cheeks, as marked **A** in the diagram. His mother reports that these lesions first appeared around age 4 years. Brain MRI reveals cortical tubers and subependymal nodules. Based on the clinical presentation and the facial lesions marked **A**, which of the following best explains the underlying pathogenesis of these skin manifestations in this patient?

Explanation

## Why option 1 is correct The symmetric facial papules marked **A** are facial angiofibromas (formerly misnamed "adenoma sebaceum"), a major diagnostic criterion for tuberous sclerosis complex (TSC). TSC is caused by autosomal dominant loss-of-function mutations in either TSC1 (hamartin, 9q34, 25% of cases) or TSC2 (tuberin, 16p13, 75% of cases). The TSC1/TSC2 protein complex normally inhibits mTORC1; when mutated, this inhibition is lost, resulting in unchecked mTOR activation. This aberrant mTOR signaling drives hamartoma formation throughout multiple organ systems, including the skin (angiofibromas), brain (cortical tubers, subependymal nodules), kidneys (angiomyolipomas), and heart (rhabdomyomas). The patient's constellation of seizures, intellectual disability, cortical tubers, and facial angiofibromas is pathognomonic for TSC with mTOR pathway dysregulation (International TSC Consensus Criteria 2012; Nelson Pediatrics 21st ed). ## Why each distractor is wrong - **Option 2 (PTEN mutations)**: PTEN loss causes Cowden syndrome, characterized by macrocephaly, hamartomas, and increased cancer risk, but NOT the specific combination of facial angiofibromas, ash-leaf macules, cortical tubers, and seizures seen in TSC. PTEN acts upstream of PI3K-AKT, not mTOR directly. - **Option 3 (MITF mutations)**: MITF (microphthalmia-associated transcription factor) defects cause Waardenburg syndrome and are associated with pigmentary abnormalities and deafness, not hamartomatous lesions or seizures. This does not explain the pathogenesis of angiofibromas or CNS involvement. - **Option 4 (Autosomal recessive DNA mismatch repair)**: Lynch syndrome and other mismatch repair defects predispose to colorectal and other cancers, not hamartomas. TSC is autosomal dominant, not recessive, and does not involve mismatch repair defects. **High-Yield:** TSC = TSC1/TSC2 loss → unchecked mTOR → hamartomas (skin, brain, kidney, heart); mTOR inhibitors (everolimus, sirolimus) are therapeutic. [cite: International TSC Consensus Criteria 2012; Nelson Pediatrics 21st ed]